Pfizer Inc. (NYSE: PFE) reported second quarter 2022 earnings results today. Total revenues increased 47% year-over-year to $27.7 billion. Reported net income rose 78% to $9.9 billion, or $1.73 per share, compared to last year. Adjusted EPS jumped 92% YoY to $2.04. Pfizer raised its revenue and adjusted EPS guidance for the full year of […]
“Pfizer Inc. (NYSE: PFE) reported second quarter 2022 earnings results today. Total revenues increased 47% year-over-year to $27.7 billion. Reported net income rose 78% to $9.9 billion, or $1.73 per share, compared to last year. Adjusted EPS jumped 92% YoY to $2.04. Pfizer raised its revenue and adjusted EPS guidance for the full year of […]
· July 28, 2022
Pfizer Inc. (NYSE: PFE) reported second quarter 2022 earnings results today.
Total revenues increased 47% year-over-year to $27.7 billion.
Reported net income rose 78% to $9.9 billion, or $1.73 per share, compared to last year. Adjusted EPS jumped 92% YoY to $2.04.
Pfizer raised its revenue and adjusted EPS guidance for the full year of 2022. The company now expects revenue of 98-102 billion and adjusted EPS of $6.30-6.45 for the year, reflecting operational growth of 27-32% and 63-67% respectively.
